Skip to search formSkip to main contentSkip to account menu

Vaginal Gel

Known as: Vaginal Gel Dose Form, VaginalGel, Vaginal Gel Dosage Form 
A gel composed of active and/or inert ingredient(s), intended for administration in or around the vagina.
National Institutes of Health

Related topics

Related topics

13 relations
Benzalkonium Chloride 0.001 MG/MG Vaginal GelDinoprostone 0.000167 MG/MG Vaginal Gel [Prepidil]Metronidazole 0.0075 MG/MG Vaginal Gel [MetroGel]Metronidazole Vaginal Gel

Broader (1)

Vaginal Creams, Foams, and Jellies

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause
Abstract Aim To evaluate the effects of the vaginal erbium laser (VEL) in the treatment of postmenopausal women suffering from… 
Highly Cited
2013
Highly Cited
2013
MTN-001: Randomized Pharmacokinetic Cross-Over Study Comparing Tenofovir Vaginal Gel and Oral Tablets in Vaginal Tissue and Other Compartments
Background Oral and vaginal preparations of tenofovir as pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV… 
Review
2010
Review
2010
Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets.
Highly Cited
2008
Highly Cited
2008
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.
BACKGROUND Women make up more than 50% of adults living with human immunodeficiency virus (HIV) infection or the acquired… 
Highly Cited
2006
Highly Cited
2006
Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: β-cyclodextrin complex
The purpose of this study was to achieve a better therapeutic efficacy and patient compliance in the treatment for vaginitis… 
Highly Cited
2006
Highly Cited
2006
Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women
Objectives:To establish the highest practical dose and frequency (HPDF) of 0.3% or 1% tenofovir vaginal gel applied once or twice… 
Highly Cited
2006
Highly Cited
2006
Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.
Highly Cited
2000
Highly Cited
2000
Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide
Objective: We sought to determine the safety and acceptability of vaginal gel formulation PC-503 among low risk, abstinent women… 
Highly Cited
1997
Highly Cited
1997
Transvaginal Administration of Progesterone
Highly Cited
1996
Highly Cited
1996
Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)